<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2010, p. 620&#226;&#8364;&#8220;626                                                                       Vol. 54, No. 2 <br /> 0066-4804/10/$12.00 doi:10.1128/AAC.01025-09 <br /> Copyright &#194;&#169; 2010, American Society Microbiology. All Rights Reserved. <br />  <br />  <br />  <br />         Newly Identified Antibacterial Compounds Are Topoisomerase <br />                       Poisons African Trypanosomes&#228;&#338;&#164; <br />                                           Sonya C. Tang Theresa A. Shapiro* <br />                 Division Clinical Pharmacology, Department Medicine, The Johns Hopkins University School of <br />                                                Medicine, Baltimore, Maryland 21205 <br />                       Received 21 July 2009/Returned modification 24 September 2009/Accepted 6 December 2009 <br />  <br />             Human African trypanosomiasis, caused Trypanosoma brucei protozoan parasite, fatal left <br />           untreated. Current therapies antiquated, need new pharmacologic agents T. <br />           brucei targets human ortholog. Trypanosomes single mitochondrion unique <br />           mitochondrial DNA, known kinetoplast DNA (kDNA), topologically complex network contains <br />           thousands interlocking circular DNAs, termed minicircles (&#226;&#172;&#402;1 kb) maxicircles (&#226;&#172;&#402;23 kb). Replication of <br />           kDNA depends topoisomerases, enzymes catalyze reactions change DNA topology. T. brucei an <br />           unusual type IA topoisomerase dedicated kDNA metabolism. This enzyme ortholog humans, <br />           <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-97' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi) studies shown essential parasite <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-5' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span>survival</span>, making ideal <br />           drug target. In large chemical library screen, compounds recently identified poisons bacterial <br />           topoisomerase IA. We compounds trypanocidal low micromolar range they <br />           promote formation linearized minicircles covalently bound protein 5&#226;&#180;&#8226; end, consistent the <br />           poisoning mitochondrial topoisomerase IA. Surprisingly, however, band depletion studies showed is <br />           topoisomerase IImt, topoisomerase IAmt, trapped. Both compounds planar aromatic <br />           polycyclic structures intercalate unwind DNA. These findings reinforce utility topoisom- <br />           erase IImt target development new drugs African sleeping sickness. <br />  <br />  <br />    Human African trypanosomiasis, known African                     intermediates, reattachment network progeny <br /> sleeping sickness, protozoal infection caused Trypano-              minicircles, retain nicks gaps circles have <br /> soma brucei fatal treatment (3). Parasites              replicated. Every step kDNA replication depends on <br /> transmitted humans tsetse fly, exclu-             function topoisomerases. These enzymes catalyze reac- <br /> sively sub-Saharan Africa limits geographic                 tions alter topological state DNA cleaving the <br /> distribution disease. Currently, estimated              phosphodiester backbone formation covalent <br /> 50,000 70,000 cases (25). Despite lethality sleeping              phosphotyrosine link, transferring segments DNA through <br /> sickness, drugs currently available treatment               break, ligating DNA (topoisomer- <br /> toxic require parenteral administration (10). In addi-             ases reviewed references 7, 9, 28). They classi- <br /> tion obstacles, resistance growing concern,             fied types, based number DNA strands <br /> and availability cost major problems population             cleaved: type I enzymes cleave strand type II en- <br /> affected. In light issues, new drugs African trypano-          zymes cleave strands reactions requiring ATP. Type I <br /> somiasis demand. The recently completed T. brucei                    enzymes classified A B subfamilies based <br /> genome sequence possible identification po-                 structural mechanistic differences. Topoisomerase IA <br /> tential drug targets essential trypanosomes and <br />                                                                             enzymes catalyze relaxation negatively supercoiled DNA <br /> have human ortholog (2). <br />                                                                             &#226;&#8364;&#339;enzyme bridging mechanism.&#226;&#8364;? After cleavage a <br />    Trypanosomes single mitochondrion unusual <br />                                                                             single strand, topoisomerase IA remains covalently bound <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> <br /> mitochondrial DNA, known kinetoplast DNA (kDNA). The <br />                                                                             5&#226;&#172;&#732; end processively unwinds DNA. If enzyme <br /> kinetoplast massive topologically complex structure, <br />                                                                             acts preexisting nick, pass double helix <br /> comprised thousands interlocked &#226;&#172;&#402;1-kb DNA minicircles <br />                                                                             resulting double-stranded break. The type II en- <br /> and dozen &#226;&#172;&#402;23-kb maxicircles (structure replication <br />                                                                             zymes utilize 5&#226;&#172;&#732;-end linkage catalysis, contrast <br /> of kDNA reviewed reference 16). This intricate network <br /> is striking contrast monomeric circular DNA                     IB topoisomerases, create covalent link 3&#226;&#172;&#732; end <br /> molecule copies human mitochon-                    cleavage site. <br /> drion. Replication kDNA requires release individ-                    T. brucei catalytically active topoisomerases, and <br /> ual covalently closed minicircles network                   appear function exclusively mitochondrion: <br /> pool &#226;&#8364;&#339;free&#226;&#8364;? minicircles, DNA synthesis theta structure               topoisomerase IAmt topoisomerase IImt (15, 21). These mi- <br />                                                                             tochondrial enzymes especially attractive drug targets since <br />                                                                             essential according RNA interference (RNAi) and <br />   * Corresponding author. Mailing address: Johns Hopkins University         drug studies (21), depletion leads akinetoplasty <br /> School Medicine, 301 Hunterian Building, 725 North Wolfe Street, <br />                                                                             (the loss kDNA), turn results death (13). <br /> Baltimore, MD 21205. Phone: (410) 955-1888. Fax: (410) 955-2634. <br /> E-mail: tshapiro@jhmi.edu.                                                     Compounds target topoisomerases classified as <br />   &#228;&#338;&#164; <br />     Published ahead print 14 December 2009.                           poisons nonpoisoning inhibitors (17). Poisons bind the <br />  <br />                                                                       620 <br />  VOL. 54, 2010                                                                         ANTITRYPANOSOMAL TOPOISOMERASE POISONS                                       621 <br />  <br />                                                                                     ogies, Inc.). Compounds 1895 0020 purchased ChemDiv (San <br />                                                                                     Diego, CA; catalog numbers 4333-1895 4711-0020, respectively), dissolved in <br />                                                                                     dimethyl sulfoxide (DMSO), aliquoted, stored &#226;&#171;&#186;20&#194;&#176;C. <br />                                                                                        Cytotoxicity assay. Compounds 1895 0020 assayed antitrypano- <br />                                                                                     somal activity using acid phosphatase-based 96-well plate method (4). Briefly, <br />                                                                                     100 &#226;?&#174;l cells (2 &#226;&#171;&#187; 105/ml) incubated 100 &#226;?&#174;l medium containing <br />                                                                                     solvent 2&#226;&#171;&#187; serially diluted compound (20 24 h, 37&#194;&#176;C). Each concentration <br />                                                                                     assayed quadruplicate. Final DMSO concentrations did exceed 1%. <br />                                                                                     Lethality confirmed microscopic examination motility. Acid phos- <br />                                                                                     phatase activity surviving cells measured adding 20 &#226;?&#174;l buffer <br />                                                                                     containing 20 mg/ml p-nitrophenyl phosphate 1 M sodium acetate, pH 5.5, 1% <br />    FIG. 1. Molecular structure 1895 (A), N,N-dimethyl-2-                Triton X-100 (5 h, 37&#194;&#176;C). Absorbance measured 405 nm. Each compound <br /> (phenanthro[3,4-d][1,3]dioxol-5-yl)ethanamine, 0020 (B),               assayed times. Curve fitting 50% effective concentration (EC50) <br /> 2-(piperidin-1-ylmethyl)indeno[1,2,3-de]phthalazin-3-(2H)-one. Of in-               determinations obtained Emax model (12) DeltaGraph Pro 3.5. <br /> terest, 1895 contains methylenedioxy motif seen etoposide                 Based Chauvenet&#226;&#8364;&#8482;s criterion (26), values (of 576 total) wells were <br /> and semisynthetic derivatives camptothecin, topo-                 identified outliers dropped analysis. <br /> isomerase poisons.                                                                     Free minicircle profiles. For concentration, 12 &#226;?&#174;l 10&#226;&#171;&#187; compound was <br />                                                                                     added 1.2 &#226;&#171;&#187; 107 cells 108 &#226;?&#174;l medium (30 min, 37&#194;&#176;C). Just lysis, a <br />                                                                                     portion taken Western blot analysis (see below). The remaining cells <br />                                                                                     lysed equal volume 10 mM Tris HCl, pH 8.0, 75 mM Na2-EDTA, <br /> Michaelis complex comprised DNA enzyme, forming                            1% SDS, 2 mg/ml proteinase K (2 h, 55&#194;&#176;C), treated with <br /> ternary DNA-protein-inhibitor &#226;&#8364;&#339;cleavable complex.&#226;&#8364;? In situ,                         100 &#226;?&#174;g/ml RNase A (30 min, 37&#194;&#176;C). Samples separated electrophoresis <br /> the presence poison prevents strand ligation, thus,                    1.5% agarose gels containing 89 mM Tris <span id='am-159' about='xsp:base' typeof='owl:Thing'>base</span>, 89 mM boric acid, 2 mM <br />                                                                                     EDTA 1 &#226;?&#174;g/ml ethidium bromide (35 V, 24 h). DNA transferred a <br /> topoisomerase remains inert complex fixed                      Hybond XL membrane (GE Healthcare), washed 750 mM NaCl 75 mM <br /> DNA helix. Covalent adducts topoisomerase DNA                            sodium citrate, UV cross-linked (Stratagene UV Cross-linker 1800) mem- <br /> be forged rapid denaturation topoisomerase                           branes, hybridized Church-Gilbert solution 32P-labeled probe that <br /> detergents sodium dodecyl sulfate (SDS). Nonspecific                        recognizes 124-bp conserved minicircle sequence (overnight, 45&#194;&#176;C) (21). <br />                                                                                     Membranes exposed PhosphorImager plate scanned (Fuji <br /> inhibitors decrease topoisomerase activity pro- <br />                                                                                     BAS 2500 PhosphorImager) visualized Image Gauge version 3.45 (Fuji <br /> mote formation cleavable complexes. They include                         Photo Films Company). Unless indicated otherwise, Adobe Photoshop used <br /> agents deform DNA substrate, bind proteins high                       adjust contrast brightness only. <br /> affinity, compete binding active sites, DNA                          Exonuclease treatment. Trypanosomes treated 25.5 &#226;?&#174;M 1895 or <br /> and ATP analogs. In cell, stationary cleavable complexes                        63 &#226;?&#174;M 0020 (1 h, 37&#194;&#176;C) lysed digested proteinase K and <br />                                                                                     RNase A, described above. DNA extracted buffer-saturated phenol <br /> prove lethal replication machinery collides them,                         phenol-chloroform-isoamyl alcohol (25:24:1), followed back <br /> producing breaks DNA (11, 17). Therapeutically useful                        extraction ethanol precipitation. Samples redissolved 100 &#226;?&#174;l 10 <br /> topoisomerase-targeting agents poisons: fluoroquinolo-                      mM Tris HCl, pH 8.0, 1 mM Na2-EDTA; applied QiaAmp DNA microkit <br /> nes etoposide topoisomerase II poisons antibacte-                       (Qiagen) cleanup; eluted 30 &#226;?&#174;l distilled water; treated 10 U &#226;?&#173; <br /> rial antitumor therapy, respectively, camptothecin                     exonuclease buffer containing 67 mM glycine-KOH, pH 9.4, 2.5 mM MgCl2, <br />                                                                                     50 &#226;?&#174;g/ml bovine serum albumin (BSA) 10 U exonuclease III buffer <br /> an antitumor agent poisons topoisomerase IB. For T.                            containing 10 mM Bis-Tris-propane-HCl, pH 7.0, 10 mM MgCl2, 1 mM dithio- <br /> brucei, poisons topoisomerase IAmt ideal                           threitol final volume 40 &#226;?&#174;l (30 min, 37&#194;&#176;C). HindIII-linearized pBluescript <br /> since enzyme human ortholog exclu-                         (80 ng) added treatment internal control. Minicircle DNA was <br /> sively mitochondrion kDNA (21).                                         separated visualized described above. <br />                                                                                        Western blot band depletion. The 8 &#226;&#171;&#187; 106 cells reserved lysed with <br />    Recently, luciferase reporter detects accumu- <br />                                                                                     equal volume 117 mM Tris HCl, pH 6.8, 3.4% SDS, 10% glycerol, 0.2 M <br /> lation covalent DNA complexes recombinant Yersinia                          dithiothreitol, 0.004% bromophenol blue. Proteins separated SDS- <br /> pestis topoisomerase IA Escherichia coli developed (8). The                  PAGE transferred polyvinyl difluoride membranes (Millipore). Blots <br /> system used high-throughput assay screen com-                       blocked 3% bovine serum albumin 25 mM Tris HCl, pH 7.4, 150 <br /> pounds poisoned Y. pestis topoisomerase IA. Three com-                         mM NaCl, 0.05% Tween 20, probed following primary then <br />                                                                                     secondary antibodies: anti-c-Myc (1:1,000; Santa Cruz Biotechnologies)&#226;&#8364;&#8220;anti- <br /> pounds promote intracellular cleavable complex                        rabbit-horseradish peroxidase (anti-rabbit-HRP; 1:20,000; Santa Cruz Biotech- <br /> formation recombinant topoisomerase IA inhibit                        nologies) anti-T. brucei-topoisomerase IImt (1:5,000 [15])&#226;&#8364;&#8220;anti-guinea pig- <br /> relaxation DNA isolated enzyme. These compounds                           HRP (1:40,000; Sigma). Loading control provided anti-human enolase <br /> also inhibited growth bacterial cells.                                       (1:200; Santa Cruz Biotechnologies)&#226;&#8364;&#8220;anti-rabbit-HRP (1:30,000). Quantitation <br />                                                                                     Image J (1). <br />    Lead compounds 1 2 identified Y. pestis model <br />                                                                                        Precipitation topoisomerase-DNA complexes. The ability compounds <br /> (Fig. 1), referred 1895 0020, respectively,                     1895 0020 promote intracellular cleavable complex formation nuclear <br /> were tested T. brucei assess cytotoxic activity                      DNA determined potassium-SDS (KSDS) assay (5, 27). Trypanosomes <br /> ability poison topoisomerase IAmt. These compounds                          (107 cells ml) thymidine-free medium radiolabeled 333 &#226;?&#174;Ci/ml <br /> found trypanocidal micromolar concentrations,                         [3H]thymidine (20 Ci/mmol; Perkin-Elmer; 1 h, 37&#194;&#176;C), washed times, <br />                                                                                     resuspended 107 cells/ml, treated DMSO, 500 &#226;?&#174;M etoposide, 50 &#226;?&#174;M <br /> appear intercalate DNA, and, unexpectedly, pro-                        1895, 50 &#226;?&#174;M 0020 (30 min, 37&#194;&#176;C). Samples assayed triplicate. An equal <br /> mote linearization free minicircles poisoning intracellular                   volume lysis buffer (1.25% SDS, 5 mM EDTA, 0.4 mg/ml calf thymus DNA) <br /> topoisomerase IImt.                                                                 added, lysates incubated (10 min, 65&#194;&#176;C). Covalent DNA-protein <br />                                                                                     complexes precipitated addition ice-cold 65 mM KCl washed <br />                                                                                     times 10 mM Tris HCl, pH 8.0, 100 mM KCl, 1 mM EDTA, 0.1 mg/ml <br />                         MATERIALS AND METHODS <br />                                                                                     calf thymus DNA, radioactivity counted liquid scintillation. Total <br />   All experiments performed bloodstream-form Trypanosoma brucei           incorporation radioactivity control cells measured triplicate by <br /> brucei (MiTat 1.2 strain 427; doubling time, 6 8 h), containing c-Myc-tagged   aliquoting 5 &#226;&#171;&#187; 105 untreated labeled cells glass filter paper precipitating <br /> topoisomerase IA allele (21), grown 37&#194;&#176;C HMI-9 containing 10% fetal           DNA 5% ice-cold trichloroacetic acid. To calculate percentage DNA <br /> bovine serum, 10% Serum Plus, 0.8 &#226;?&#174;g/ml G418 (Gibco BRL Life Technol-           trapped cleavable complexes, averaged counts minute detected in <br />  622      TANG AND SHAPIRO                                                                                        ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />  <br />  <br />   FIG. 2. Killing activity T. brucei vitro 1895 (A) 0020 (B). For concentration tested (assayed quadruplicate), the <br /> coefficients variation 10%. Data fitted equation Emax model obtain EC50s; R2 values 0.99 graphs. <br />  <br />  <br />  <br /> KSDS precipitates divided averaged counts minute trichloro-   appears decrease linear forms, rebound <br /> acetic acid precipitates.                                                        120 &#226;?&#174;M. This wavering <span id='am-160' about='xsp:pattern' typeof='owl:Thing'>pattern</span> observed repro- <br />    DNA unwinding. DNA unwinding 1895 0020 assayed described <br /> previously (24). In brief, 250 ng supercoiled pBluescript pBluescript <br />                                                                                  ducibly experiments. <br /> relaxed Escherichia coli topoisomerase IA treated various concen-       Linear forms expected product 1895 and <br /> trations 1895 0020 50 mM Tris HCl, pH 7.5, 50 mM NaCl, 5 mM        0020 poisoning topoisomerase IAmt. Since type I enzymes <br /> MgCl2, 1 pM vaccinia virus topoisomerase IB (gift James         make single-stranded break, poisoning lead to <br /> Stivers) added (1 h, 37&#194;&#176;C). Reactions quenched addition 10&#226;&#171;&#187; <br /> DNA loading dye containing 0.625% SDS, 0.125% xylene cyanol, 0.125% bro- <br />                                                                                  increase nicked, linearized, minicircles. However, the <br /> mophenol blue, 62.5% glycerol. DNA separated 1% agarose 89 mM          population nicked/gapped minicircles treated cells is <br /> Tris base, 89 mM boric acid, 2 mM EDTA visualized ethidium bromide        comparable controls (Fig. 3B 3C). Perhaps if <br /> fluorescence.                                                                    topoisomerase IAmt works preexisting nick a <br />                                                                                  minicircle molecules topoisomerase IAmt work <br />                                 RESULTS                                          adjacent opposite strands, linear forms could <br />                                                                                  generated treatment compounds 1895 0020. <br />    Trypanocidal activity vitro. Increasing concentrations of <br />                                                                                     Linearized minicircles protected exonuclease di- <br /> 1895 0020 tested bloodstream T. brucei to <br />                                                                                  gestion. To determine protein covalently bound <br /> assess killing activity (Fig. 2). In determinations, the <br />                                                                                  5&#226;&#172;&#732; 3&#226;&#172;&#732; end cleavage sites linear forms, <br /> EC50 1895 6.3 &#226;&#171;&#190; 4.3 &#226;?&#174;M 0020 16.9 &#226;&#171;&#190; 8.8 <br />                                                                                  minicircles extracted cells treated 1895 or <br /> &#226;?&#174;M. For perspective, potencies trypanosomes are <br />                                                                                  0020 subjected &#226;?&#173; exonuclease, degrades linear <br /> comparable known topoisomerase poisons (camp- <br />                                                                                  DNA 5&#226;&#172;&#732; end, exonuclease III, degrades <br /> tothecin, 1.5 &#226;?&#174;M [4]; ciprofloxacin, 52 &#226;?&#174;M [18]) low <br />                                                                                  3&#226;&#172;&#732; end (Fig. 4). Internal control linear pBluescript was <br /> compared clinically used agents trypanosomiasis <br />                                                                                  completely digested samples containing exonuclease, ver- <br /> (pentamidine, 14 nM [4]; berenil, 94 nM [4]), difluo- <br />                                                                                  ifying enzymatic activity (Fig. 4B). Minicircle linear forms <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> romethylornithine (&#226;&#172;&#381;147 &#226;?&#174;M [29]). <br />    Compounds 1895 0020 promote minicircle lineariza-                         cells treated compound protected deg- <br /> tion. To determine antitrypanosomal activity related               radation &#226;?&#173; exonuclease exonuclease III, <br /> topoisomerase IAmt, free minicircle replication intermediates                    indicating DNA blocked protein 5&#226;&#172;&#732; end <br /> from treated cells analyzed Southern hybridization (Fig.                 (Fig. 4A). This finding rules topoisomerase IB mecha- <br /> 3). When electrophoresed presence ethidium bro-                        nism (which requires 3&#226;&#172;&#732;-phosphotyrosine link) most <br /> mide, free minicircles separated nicked/gapped daugh-                   consistent topoisomerase II, protein co- <br /> ter circles, linear forms, covalently closed template circles.               valently bound 5&#226;&#172;&#732; end strands. However, type IA <br /> As expected, etoposide, known poison T. brucei topoisom-                    enzymes bind 5&#226;&#172;&#732; end cleavage site. If the <br /> erase IImt (23), increased linearized minicircles concen-                   linear forms produced topoisomerase IAmt molecule <br /> tration-dependent fashion (Fig. 3A, left panel). These linear                    acted preexisting nick, single strand <br /> forms substantially reduced samples treated                      DNA protected digestion &#226;?&#173; exonuclease. <br /> proteinase K, consistent covalent linkage protein                  A new population minicircle DNA runs faster than <br /> (Fig. 3A, right panel).                                                          covalently closed circles does appear samples digested with <br />    Compounds 1895 0020 rise increase                      &#226;?&#173; exonuclease, present control sample <br /> protease-sensitive linear forms (Fig. 3B 3C). For 1895,                   treated &#226;?&#173; exonuclease. If topoisomerase IAmt mole- <br /> concentrations 0 40 &#226;?&#174;M, steady increase                   cules worked close proximity opposite strands, lin- <br /> in linear forms, 60 &#226;?&#174;M, population decreases                       earized forms strands protected 5&#226;&#172;&#732; end could <br /> (Fig. 3B). Based proteinase K sensitivity, 80 100 &#226;?&#174;M,                  produced. <br /> the linear forms protein bound. For 0020, pattern                       Depletion free topoisomerase cell lysates. To deter- <br /> of protein-bound linear forms complicated (Fig. 3C).                     mitochondrial topoisomerase covalently linked <br /> In presence proteinase K, linear forms increase steadily                  linearized minicircles, lysates treated cells analyzed <br /> between 0 40 &#226;?&#174;M level 80 &#226;?&#174;M. At 100 &#226;?&#174;M                      immunoblotting. In method, topoisomerase enzyme <br />  VOL. 54, 2010                                                                  ANTITRYPANOSOMAL TOPOISOMERASE POISONS                             623 <br />  <br />  <br />  <br />  <br />    FIG. 3. Free minicircle profiles. T. brucei treated indicated lysed SDS buffer. Lysates digested (or not) proteinase <br /> K, indicated, DNA separated electrophoresis prior Southern blotting minicircle DNA. (A) Lanes 1 4, 0, 4, 20, 100 &#226;?&#174;M <br /> etoposide, respectively (5 &#226;&#171;&#187; 106 cells/lane). (B) Lanes 1 7, 0, 10, 20, 40, 60, 80, 100 &#226;?&#174;M 1895, respectively (1.7 &#226;&#171;&#187; 106 cells/lane). (C) Lanes <br /> 1 6, 0, 20, 40, 80, 100, 120 &#226;?&#174;M 0020, respectively (1.7 &#226;&#171;&#187; 106 cells/lane). Samples treated 10 60 &#226;?&#174;M incomplete proteolysis and <br /> are shown. The position lanes blot switched present results increasing concentrations. N/G, nicked/gapped; L, <br /> linear; CC, covalently closed. <br />  <br />  <br />                                                                              covalently bound DNA unable enter gel matrix and <br />                                                                              free topoisomerase molecules detected (14). As ex- <br />                                                                              pected, etoposide treatment depletes topoisomerase IImt and <br />                                                                              effect topoisomerase IAmt (Fig. 5A 5B, left <br />                                                                              panels). Interestingly, cells treated 1895 0020, there <br />                                                                              decrease topoisomerase IAmt, indicating these <br />                                                                              compounds promote cleavable complex formation with <br />                                                                              enzyme trypanosomes (Fig. 5A, central right pan- <br />                                                                              els). However, lead significant decrease free <br />                                                                              topoisomerase IImt, indicating protein respon- <br />                                                                              sible minicircle linearization (Fig. 5B, central right <br />                                                                              panels). The depletion free topoisomerase IImt 1895 and <br />                                                                              0020 reproducibly obtained inde- <br />                                                                              pendent experiments, respectively. There effect the <br />                                                                              catalytic subunit topoisomerase IB (data shown), an <br />                                                                              enzyme acts nucleus mitochondrion of <br />                                                                              trypanosomes (5). <br />                                                                                 Nuclear topoisomerase II trapped cleavable com- <br />    FIG. 4. Exonuclease susceptibility minicircle DNA                 plexes. To assess possible effect nuclear topo- <br /> treated T. brucei. Cells treated drug, 25.5 &#226;?&#174;M 1895, or <br /> 63 &#226;?&#174;M 0020 indicated lysed SDS. Internal control                 isomerases, utilized KSDS assay. Since 95% DNA in <br /> HindIII-linearized pBluescript added sample prior             trypanosomes nuclear (6), assay monitors cleavable com- <br /> exonuclease treatment. (A) Southern blot minicircle DNA. Lanes            plex formation nucleus. In experiment, total <br /> 1, 4, 7, exonuclease. Lanes 2, 5, 8, &#226;?&#173; exonuclease. Lanes         incorporation [3H]thymidine 3.7 &#226;&#171;&#187; 105 cpm/107 cells. In <br /> 3, 6, 9, exonuclease III. There 2.45 &#226;&#171;&#187; 107 cells/lane. <br /> (B) Reaction internal control pBluescript DNA visualized by <br />                                                                              presence DMSO, 2.2% total DNA covalently <br /> ethidium bromide fluorescence prior DNA transfer minicircle           bound protein precipitated, attributable naturally <br /> hybridization.                                                               occurring topoisomerase catalytic complexes situ (Table 1). <br />  624       TANG AND SHAPIRO                                                                                          ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br />  <br />  <br />    FIG. 5. Western blots T. brucei proteins treatment indicated SDS lysis. (A) Free topoisomerase IAmt signals enolase <br /> controls. (Left) Lanes 1 3, 0, 4, 100 &#226;?&#174;M etoposide, respectively (1 &#226;&#171;&#187; 106 cells/lane). (Center) Lanes 1 5, 0, 40, 60, 80, 100 &#226;?&#174;M 1895, <br /> respectively (8.33 &#226;&#171;&#187; 105 cells/lane). (Right) Lanes 1 5, 0, 20, 60, 100, 120 &#226;?&#174;M 0020, respectively (8.33 &#226;&#171;&#187; 105 cells/lane). In far-right panel <br /> these results quantitated correcting topoisomerase signal cognate enolase control normalizing treated samples <br /> to untreated controls. Etoposide, filled circles; 1895, filled squares; 0020, filled triangles. (B) Free topoisomerase IImt signals enolase controls; <br /> concentrations panel A. Membranes hybridized antibodies c-Myc (&#226;?&#163;-cMyc) visualize c-Myc-tagged topoisomerase IAmt, to <br /> topoisomerase IImt (&#226;?&#163;-IImt), enolase (&#226;?&#163;-en). In far-right panel, quantitation symbols given above. The quantitative data for <br /> all panels verified analysis independent investigator. <br />  <br />  <br />  <br /> As expected, etoposide increased signal four-                        prior electrophoresis. The binding intercalators as <br /> fold. In trypanosomes, trapping nuclear topoisomerase                        ethidium bromide causes DNA helix unwind form <br /> II apparent etoposide concentrations low 1 &#226;?&#174;M                       positive supertwists. In presence topoisomerase these <br /> is maximal &#226;&#172;&#402;100 &#226;?&#174;M (data shown). For Table 1, 500                        relaxed equilibrium, topoisomerase and <br /> &#226;?&#174;M concentration utilized ensure robust positive                           intercalator subsequently removed, DNA hy- <br /> control. Interestingly, contrast etoposide, 1895                     pernegatively supercoiled. In absence added compound, <br /> and 0020 reduced cleavable complex formation nuclear                           vaccinia virus topoisomerase IB relaxes DNA substrates <br /> DNA, concentrations maximize linearization                           (Fig. 6A D, lanes 2). However, relaxation occurs the <br /> minicircles (Fig. 3 Table 1).                                                   presence ethidium bromide, isolated products hy- <br />    Compounds 1895 0020 unwind DNA. The polycyclic,                              pernegatively supercoiled (Fig. 6A D, lanes 3 4). This <br /> aromatic, planar structures 1895 0020 suggest                     unwinding effect seen, concentration-dependent <br /> compounds DNA intercalators. To assess possibil-                        fashion, 1895 0020 DNA substrates were <br /> ity, plasmid DNA incubated various concentrations                       negatively supercoiled relaxed (Fig. 6A D, lanes 5 10). <br /> 1895 0020 treated vaccinia virus topoisomerase IB, <br />                                                                                                             DISCUSSION <br />  <br />           TABLE 1. In situ formation topoisomerase-DNA                              With discovery essential mitochondrial topoisom- <br />                         cleavable complexes                                         erase IAmt T. brucei ortholog humans (21), it <br />                                               Cleavable complexes                   great study effects African trypano- <br />       Compounda <br />         (&#226;?&#174;M)                                                                        somes newly described antibacterial topoisomerase IA poi- <br />                                 % total DNAb                 Ratio DMSO <br />                                                                                     sons (8). Two compounds trypanocidal activity at <br /> DMSO                               2.2 &#226;&#171;&#190; 0.05                         1.0           low micromolar concentrations. Furthermore, promoted <br /> Etoposide (500)                    9.0 &#226;&#171;&#190; 0.81                         4.2           formation covalent protein adducts minicircle <br /> 1895 (50)                          1.9 &#226;&#171;&#190; 0.09                         0.86          DNA, expected topoisomerase poisons oper- <br /> 0020 (50)                          1.7 &#226;&#171;&#190; 0.13                         0.79 <br />                                                                                     ating mitochondrion trypanosomes. Protein at- <br />   a <br />     Each compound assayed triplicate.                                        tached 5&#226;&#172;&#732; end minicircle DNA, consistent poi- <br />   b <br />     KSDS-precipitable radioactivity treated cells, percentage trichlo- <br /> roacetic acid-precipitable radioactivity untreated cells. Values means &#226;&#171;&#190;     soning type IA enzyme. However, band depletion studies <br /> standard deviations.                                                                unexpectedly revealed enzyme captured the <br />  VOL. 54, 2010                                                              ANTITRYPANOSOMAL TOPOISOMERASE POISONS                                     625 <br />  <br />  <br />                                                                           tween chromosomal DNA minicircle DNA. It pos- <br />                                                                           sible compounds selectively concentrated the <br />                                                                           mitochondrion. <br />                                                                              Ability intercalate DNA explain varia- <br />                                                                           tion seen reproducibly accumulation linearized <br />                                                                           minicircles function concentration 1895 0020 (Fig. <br />                                                                           3B 3C). Intercalators insert DNA bases and <br />                                                                           unwind DNA mixed effects topoisomerases. <br />                                                                           Some intercalators inhibit topoisomerases poison- <br />                                                                           ing them, seen 4&#226;&#172;&#732;-(9-acridinylamino)-methanesul- <br />                                                                           fon-o-anisidide (o-AMSA). Others, closely re- <br />                                                                           lated isomer m-AMSA, poison topoisomerase II, promote the <br />                                                                           formation double-stranded breaks, clinically useful <br />                                                                           antitumor agents (17, 19, 20). 2-Methyl-9-hydroxyellipticinium <br />                                                                           (2-Me-9-OH-E&#226;&#171;&#185;), intercalator, effect similar to <br />                                                                           observe 1895 0020: low concentrations stim- <br />                                                                           ulate cleavable complex formation topoisomerase II, at <br />                                                                           higher concentrations trapping topoisomerase II re- <br />                                                                           duced (19, 20). These effects result distortion the <br />                                                                           substrate DNA induced strong intercalators present high <br />                                                                           ratios. The intercalation effect account a <br />                                                                           decrease linearization minicircles high concentrations <br />                                                                           reduction SOS response seen high <br />                                                                           concentrations 1895 used Y. pestis model (8). In <br />                                                                           keeping intercalation effect, unwinding assay <br />    FIG. 6. DNA unwinding assay. Lanes 1 4, supercoiled relaxed      0020 appears stronger intercalator 1895, consistent <br /> plasmid DNA (lanes 1) treated topoisomerase IB (lanes      greater inhibition cleavable complex formation with <br /> 2) topoisomerase IB presence 1.0 2.5 &#226;?&#174;g/ml <br /> ethidium bromide (lanes 3 4, respectively). Lanes 5 10, topo-      nuclear DNA (Table 1). <br /> isomerase IB treatment presence 500, 250, 125, 67.5, 33.8,      Compounds 1895 0020 poison mitochondrial <br /> 16.9 &#226;?&#174;M 1895, respectively (A B), 310, 155, 77.5, 38.8, 19.4,   type IA topoisomerase T. brucei, despite ability to <br /> 9.70 &#226;?&#174;M 0020, respectively (C D). There 100 ng plasmid            poison cognate enzyme bacteria. Instead, com- <br /> DNA/lane. EtBr, ethidium bromide; IB, vaccinia virus topoisomerase <br /> IB; sc DNA, supercoiled pBluescript plasmid substrate; DNA, re- <br />                                                                           pounds act mitochondrial, nuclear, topo- <br /> laxed pBluescript plasmid substrate.                                      isomerase II trypanosomes. Though unexpected, find- <br />                                                                           ings corroborate mitochondrial topoisomerase II a <br />                                                                           suitable target development much-needed new an- <br />                                                                           titrypanosomal drugs. <br /> trypanosome&#226;&#8364;&#8482;s mitochondrial type II, type IA, topoisom- <br /> erase. Trapping mitochondrial type II enzyme                                          ACKNOWLEDGMENTS <br /> consistent protection 5&#226;&#172;&#732; end minicircle DNA, and <br />                                                                              This work supported NIH R01AI028855, National Insti- <br /> it provides satisfying explanation formation pro-            tutes Health Medical Scientist Training Grant T32GM07309, and <br /> tein-bound linearized, nicked, minicircles               PhRMA Foundation&#226;&#8364;&#8482;s Paul Calabresi Medical Student Research <br /> SDS lysis treated cells. Interestingly, T. brucei         Fellowship. The work received Excellence Medical Student <br /> a second type II topoisomerase operates nucleus,              Research award Johns Hopkins University School Medi- <br /> this enzyme poisoned 1895 0020 shown              cine. <br />                                                                              We thank Rahul Bakshi Jane Scocca assistance in <br /> KSDS assay.                                                               methodology, helpful discussions, suggestions manuscript. <br />    In trypanosomes, selective poisoning mitochondrial,             We grateful Paul Englund Robert Jensen sugges- <br /> but nuclear, topoisomerase II seen previously              tions, James Stivers providing vaccinia virus topoisomerase IB, and <br /> number structurally unrelated DNA-binding antitrypanoso-               Jeannette Fanning administrative support. <br /> mal drugs (22). This finding contrast seen with <br />                                                                                                           REFERENCES <br /> etoposide, does bind directly DNA traps both <br />                                                                            1. Abramoff, M. D., P. J. Magelhaes, S. J. Ram. 2004. Image processing <br /> nuclear mitochondrial topoisomerase II (23). The planar                   Image J. Biophotonics Int. 11:36&#226;&#8364;&#8220;42. <br /> aromatic structure 1895 0020 suggested              2. Aguero, F., B. Al-Lazikani, M. Aslett, M. Berriman, F. S. Buckner, R. K. <br /> be acting intercalators T. brucei lead                   Campbell, S. Carmona, I. M. Carruthers, A. W. Chan, F. Chen, G. J. <br />                                                                               Crowther, M. A. Doyle, C. Hertz-Fowler, A. L. Hopkins, G. McAllister, S. <br /> differential poisoning mitochondrion nucleus. DNA                  Nwaka, J. P. Overington, A. Pain, G. V. Paolini, U. Pieper, S. A. Ralph, A. <br /> unwinding assays confirmed 1895 0020 DNA                     Riechers, D. S. Roos, A. Sali, D. Shanmugam, T. Suzuki, W. C. Van Voorhis, <br />                                                                               C. L. Verlinde. 2008. Genomic-scale prioritization drug targets: the <br /> intercalators. The exact basis selective poisoning mito-               TDR Targets database. Nat. Rev. Drug Discov. 7:900&#226;&#8364;&#8220;907. <br /> chondrial nuclear type II topoisomerases DNA-                   3. Barrett, M. P., R. J. Burchmore, A. Stich, J. O. Lazzari, A. C. Frasch, J. J. <br /> binding agents unknown, relate intrinsic dif-                Cazzulo, S. Krishna. 2003. The trypanosomiases. Lancet 362:1469&#226;&#8364;&#8220;1480. <br />                                                                            4. Bodley, A. L., M. W. McGarry, T. A. Shapiro. 1995. Drug cytotoxicity <br /> ferences enzymes, phylogenetically quite                 assay African trypanosomes Leishmania species. J. Infect. Dis. 172: <br /> distinct (15), marked structural differences be-                1157&#226;&#8364;&#8220;1159. <br />  626       TANG AND SHAPIRO                                                                                                  ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  5. Bodley, A. L., T. A. Shap <br /> </body></html>